Gait Analysis in Neurological Disease

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

March 1, 2016

Primary Completion Date

June 20, 2026

Study Completion Date

June 20, 2026

Conditions
Parkinson's DiseaseParkinsonian DisordersAtypical Parkinson DiseaseProgressive Supranuclear PalsyMultiple System AtrophyCorticobasal DegenerationGait, FrontalHuntington Disease
Interventions
DRUG

Anti-Parkinson medication

During the optional second visit subjects with neurological disease and already on anti-parkinson medication are asked to come off their anti-parkinson medication.

DEVICE

Deep Brain Stimulation

During the optional second visit subjects with neurological disease already treated with deep brain stimulation are asked to come temporarily stop deep brain stimulation and resume stimulation, with walking trials done in each condition.

Trial Locations (1)

02215

RECRUITING

Clinical Research Center BIDMC, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER